TORNTPHARM.NS Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 май 2024 @ 13:00):

Stats
Объем за сегодня	262 264
Средний объем	259 589
Рыночная капитализация	919.62B
EPS	INR0 ( 2024-02-02 )
Дата следующего отчета о доходах	( INR0 ) 2024-05-28
Last Dividend	INR8.00 ( 2023-06-23 )
Next Dividend	INR0 ( N/A )
P/E	61.71
ATR14	INR3.44 (0.13%)

Объем Корреляция

Длинно: 0.48 (neutral)

Кратко: 0.48 (neutral)

Signal:(47.194) Neutral

Torrent Pharmaceuticals Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Torrent Pharmaceuticals Корреляция - Валюта/Сырье

0.73
( moderate )

0.53
( weak )

0.77
( moderate )

0.54
( weak )

0.45
( neutral )

-0.09
( neutral )

Torrent Pharmaceuticals Финансовые показатели

Annual	2022
Выручка:	INR94.64B
Валовая прибыль:	INR67.29B (71.10 %)
EPS:	INR36.79

FY	2022
Выручка:	INR94.64B
Валовая прибыль:	INR67.29B (71.10 %)
EPS:	INR36.79

FY	2022
Выручка:	INR84.19B
Валовая прибыль:	INR58.81B (69.86 %)
EPS:	INR22.97

FY	2021
Выручка:	INR78.86B
Валовая прибыль:	INR56.51B (71.66 %)
EPS:	INR36.99

Financial Reports:

No articles found.

Torrent Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR14.00 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Torrent Pharmaceuticals Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.99 - low (32.75%) | Divividend Growth Potential Score: 4.25 - Stable (14.91%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2003-06-10
Last Dividend	INR8.00	2023-06-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	32	--
Total Paid Out	INR130.50	--
Avg. Dividend % Per Year	0.85%	--
Score	2.4	--
Div. Sustainability Score	3.99
Div.Growth Potential Score	4.25
Div. Directional Score	4.12	--

Next Divdend (Est)
(2024-09-12)

INR8.12 Estimate 6.85 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.40

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR7.00	1.01%
2019	INR8.50	0.96%
2020	INR7.50	0.81%
2021	INR17.50	1.25%
2022	INR20.00	1.23%
2023	INR22.00	1.42%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SILINV.NS	Dividend Junior	2023-08-18	Annually	23	0.63%
MBAPL.NS	Dividend Junior	2023-09-18	Annually	8	0.44%
GUJAPOLLO.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.48%
BAYERCROP.NS	Dividend Junior	2023-08-03	Annually	15	1.25%
PREMIERPOL.NS	Dividend Junior	2023-09-11	Sporadic	9	0.39%
KAMDHENU.NS	Dividend Junior	2023-08-14	Sporadic	17	0.32%
EDELWEISS.NS	Dividend Junior	2023-09-18	Annually	17	2.38%
ADSL.NS	Dividend Junior	2023-08-10	Sporadic	16	0.91%
STERTOOLS.NS	Dividend Junior	2023-09-11	Annually	19	0.38%
NAHARCAP.NS	No Dividend Player	2023-09-08	Annually	17	0.70%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.09	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.233	1.500	8.52	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.33	1.000	8.77	8.77	[3 - 30]
operatingCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.737	1.000	1.045	1.045	[0.2 - 0.8]
operatingProfitMarginTTM	0.234	1.000	7.32	7.32	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.99

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	61.14	1.000	3.93	0	[1 - 100]
returnOnEquityTTM	0.233	2.50	9.05	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.105	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	47.33	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-1.612	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.155	1.000	8.62	0	[0.1 - 0.5]
Total Score				4.25

Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.